Week of August 19, NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends. Data Provided by Refinitiv. Minimum 15 minutes delayed. Investor Tools. Salarius. Footer Nav. About Us · Overview · Leadership Team · Board of Directors. SLRX Stock Overview · Clinical Data on Salarius Pharmaceuticals' Seclidemstat in Patients with Mds and Cmml Presented At the European Hematology Association. Predictive Oncology Inc. $ POAI % ; Windtree Therapeutics Inc. $ WINT % ; QXO Inc. $ QXO % ; Staffing Solutions Inc. $ STAF. Salarius Pharmaceuticals Inc. ; Volume, M ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A.
Salarius Pharmaceuticals Stock (NASDAQ: SLRX) stock price, news, charts, stock research, profile. The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the. Discover real-time Salarius Pharmaceuticals, Inc. Common Stock (SLRX) stock prices, quotes, historical data, news, and Insights for informed trading and. The Investor Relations website contains information about Salarius Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial. Salarius Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SLRX updated stock price target summary. Beginning with the opening of trading on June 17, , Salarius' common stock will trade on the Nasdaq Capital Market on a split-adjusted basis under a new. Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split. July 12, In The News. Salarius Pharmaceuticals Cleared to Begin Phase I Trial of SP Discover real-time Salarius Pharmaceuticals, Inc. Common Stock (SLRX) stock prices, quotes, historical data, news, and Insights for informed trading and. SLRX | Complete Salarius Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. What is Salarius Pharmaceuticals, Inc. stock price today? The current price of SLRX is USD — it has decreased by −% in the past 24 hours. Watch. Track Salarius Pharmaceuticals Inc (SLRX) Stock Price, Quote, latest community messages, chart, news and other stock related information.
Salarius Pharmaceuticals (NASDAQ: SLRX) announced a 1-for-8 reverse stock split effective June 14, Trading on a split-adjusted basis will begin on June SLRX | Complete Salarius Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Data Provided by Refinitiv. Minimum 15 minutes delayed. SLRX Stock Performance ; Previous close, ; Day range, - ; Year range, 1 - 7 ; Market cap, 1,, ; Primary exchange, NASDAQ. View Salarius Pharmaceuticals, Inc. SLRX stock quote prices, financial information, real-time forecasts, and company news from CNN. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. SLRX will report Salarius Pharmaceuticals Inc SLRX:NASDAQ ; Close. quote price arrow down (%) ; Volume. 44, ; 52 week range. - HOUSTON (AP) — Salarius Pharmaceuticals, Inc. SLRX) on Friday reported a loss of $ million in its second quarter. On a per-share basis, the Houston-based. The stock symbol for Salarius Pharmaceuticals is "SLRX." What Is the Salarius Pharmaceuticals Market Cap? As of today, Salarius Pharmaceuticals market cap is.
Find the latest Salarius Pharmaceuticals, Inc. (SLRX) stock quote, history, news and other vital information to help you with your stock trading and. 36 minutes ago. Stock analysis for Salarius Pharmaceuticals Inc (SLRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. Salarius Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SLRX. The last closing price for Salarius. View Salarius Pharmaceuticals (SLRX) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo.
Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer. Track Salarius Pharmaceuticals Inc (SLRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer. PM · Salarius: Q1 Earnings Snapshot. (Associated Press Finance) ; Mar PM · SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q4 . Salarius Pharmaceuticals, Inc NASDAQ: SLRX is a biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical need. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. Predictive Oncology Inc. $ POAI % ; Windtree Therapeutics Inc. $ WINT % ; QXO Inc. $ QXO % ; Staffing Solutions Inc. $ STAF. The stock symbol for Salarius Pharmaceuticals is "SLRX." What Is the Salarius Pharmaceuticals Market Cap? As of today, Salarius Pharmaceuticals market cap is. View Salarius Pharmaceuticals, Inc. SLRX stock quote prices, financial information, real-time forecasts, and company news from CNN. Salarius Pharmaceuticals Inc. · AT CLOSE PM EDT 08/30/24 · USD · % · Volume30, Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Data Provided by Refinitiv. Minimum 15 minutes delayed. SLRX Stock Performance ; Previous close, ; Day range, - ; Year range, 1 - 7 ; Market cap, 1,, ; Primary exchange, NASDAQ. Data Provided by Refinitiv. Minimum 15 minutes delayed. Investor Tools. Salarius. Footer Nav. About Us · Overview · Leadership Team · Board of Directors. Salarius Pharmaceuticals Inc SLRX ; Valuation · Price/Earnings (Normalized). — ; Financial Strength · Quick Ratio. ; Profitability · Return on Assets (Normalized). Salarius Pharmaceuticals Stock (NASDAQ: SLRX) stock price, news, charts, stock research, profile. Buy Or Fear Salarius Pharmaceuticals (SLRX) Stock? ; Solar Acquisition (SLRX) Valuation: SLRX Stock Looks Appropriately Priced With $ Price. SLRX Stock Overview · Clinical Data on Salarius Pharmaceuticals' Seclidemstat in Patients with Mds and Cmml Presented At the European Hematology Association. SLRX has underperformed the market in the last year with a price return of % while the SPY ETF gained +%. SLRX has also underperformed the stock market. Week of August 19, NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends. Stock analysis for Salarius Pharmaceuticals Inc (SLRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. Salarius Pharmaceuticals (NASDAQ: SLRX) announced a 1-for-8 reverse stock split effective June 14, Trading on a split-adjusted basis will begin on June Salarius Pharmaceuticals Inc (SLRX) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. The current price of SLRX is USD — it has increased by % in the past 24 hours. Watch Salarius Pharmaceuticals, Inc. stock price performance more. View Salarius Pharmaceuticals (SLRX) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split · Mar 22, Salarius Pharmaceuticals Reports Fourth Quarter and Full Year Financial. Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer. Salarius Pharmaceuticals Inc SLRX:NASDAQ ; Last | 09/04/24 EDT. quote price arrow up + (+%) ; Volume. 34, ; 52 week range. - Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split. July 12, In The News. Salarius Pharmaceuticals Cleared to Begin Phase I Trial of SP
Salarius Pharmaceuticals, Inc. Stock ; Mean consensus. HOLD ; Number of Analysts. 1 ; Last Close Price. USD ; Average target price. USD ; Spread / Average. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. SLRX will report Salarius Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Salarius Pharmaceuticals, Inc. (US:SLRX) has 17 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission. What is Salarius Pharmaceuticals Inc(SLRX)'s stock price today? The current price of SLRX is $ The 52 week high of SLRX is $ and 52 week low is $